Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy
Saved in:
Main Authors: | Denny Demeria, Iain Birchall, Vincent G Bain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2007-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2007/128792 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01) -
Targeted Therapy in Hepatocellular Carcinoma
by: Clarinda W. L. Chua, et al.
Published: (2011-01-01) -
The Role of Bridging Therapy in Hepatocellular Carcinoma
by: Roberto Galuppo, et al.
Published: (2013-01-01) -
Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01) -
Multifocal Arterial Thrombosis during Thalidomide Therapy: Case Report and Review of the Literature
by: Monica Ferri, et al.
Published: (2009-01-01)